Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Invasive Ductal Breast Cancer|Tubular Breast Cancer|Mucinous Breast Cancer|Inflammatory Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Cisplatin|DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: 5-fluoruracil
Sponsor: RenJi Hospital